331
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Substance Misuse Prevention as Corporate Social Responsibility

&

REFERENCES

  • American Society of Health-System Pharmacists. (2003). ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance. American Journal of Health-System Pharmacy, 60, 1995–1998.
  • Ames, G. (1993). Research and strategies for the primary prevention of workplace alcohol problems. Alcohol Health and Research World, 17(1), 19–27.
  • Anheuser-Busch Inc. (n.d.). Retrieved January 6, 2011, from http://www.beeresponsible.com/
  • Bator, F. M. (1958). The anatomy of market failure. Quarterly Journal of Economics, 72(3), 351–379.
  • Billings, D. W., Cook, R. F., Hendrickson, A., & Dove, D. (2008). A web-based approach to managing stress and mood disorders in the workforce. Journal of Occupational and Environmental Medicine, 50, 960–968.
  • Cadbury, A. (1990). The company chairman. Cambridge: Institute of Directors.
  • Cadbury, A. (2006). Corporate social responsibility. Twenty-First Century Society, 1(1), 5–21.
  • Cook, R., & Schlenger, W. (2002). Prevention of substance abuse in the workplace: Review of research on the delivery of services. The Journal of Primary Prevention, 23(1), 115–142.
  • Cook, R. F., Back, A., & Trudeau, J. (1996). Preventing alcohol use problems among blue-collar workers: A field test of the Working People program. Substance Use and Misuse, 31(3), 255–275.
  • Cook, R. F., Back, A. S., Trudeau, J. V., & McPherson, T.L. (2003). Integrating substance abuse prevention into health promotion programs in the workplace. In Bennett & Lehman (Eds.), Beyond drug testing to wellness (pp. 97–133). Washington, DC: APA.
  • Dawkins, J. (2005). Corporate responsibility: The communication challenge. Journal of Communication Management, 9(2), 108–119.
  • Delogu, N. N. (2007). Essential elements of a drug-free workplace program. Professional Safety, November, 2007, 48–51.
  • Deitz, D., Cook, R., & Hersch, R. (2005). Workplace health promotion and utilization of health services: Follow-up findings. Journal of Behavioral Health Services and Research, 32(3), 306–319.
  • Dusenbury, L. (1999). Workplace drug abuse prevention initiatives: A review. The Journal of Primary Prevention, 20(2), 145–156.
  • Emod, P. (1999). ILO-program a vallalati alkoholfogyasztas megelozesere [ILO-program for the prevention of alcohol consumption at workplaces]. Nepszabadsag. Retrieved February 4, 2011, from http://www.afsz.hu/engine.aspx?page= alkdrogprev_tanulmanyok&switch-content=aldrogprev_tanulm anyok_cikk1&switch-zone=Zone1&switch-render-mode=full
  • European Monitoring Centre for Drugs and Drug Addiction. (n.d. a). Addiction prevention within the apprenticeship of the Austrian federal railways. EMCDDA, Best practice portal. Retrieved June 23, 2010, from http://www.emcdda.europa.eu/ html.cfm/index52035EN.html?project_id=2549&tab=overview
  • European Monitoring Centre for Drugs and Drug Addiction. (n.d. b). Pleasure of life instead of frustration with drugs. EMCDDA, Best practice portal. Retrieved June 30, 2010, from http://www.emcdda.europa.eu/modules/wbs/dsp_print_project_ description.cfm?project_id=3976
  • European Monitoring Centre for Drugs and Drug Addiction. (2009). Annual report 2009: The state of the drugs problem in Europe. Retrieved January 7, 2011, from http://www.emcdda. europa.eu/publications/annual-report/2009
  • Forrest, A. R. W. (1997). Ethical aspects of workplace urine screening for drug abuse. Journal of Medical Ethics, 23, 12–17.
  • Fox, T., Ward, H., & Howard, B. (2002). Public sector roles in strengthening Corporate Social Responsibility: A baseline study. Washington, DC: The World Bank.
  • Freeman, R. E. (1984). Strategic management: A stakeholder approach. Boston: Pitman.
  • Freeman, R. E. (2007). Managing for stakeholders. In: T. L. Beauchamp, N. E. Bowie, & D. G. Arnold. (Eds.), Ethical theory and business (8th ed.). Upper Saddle River, NJ: Pearson/Prentice Hall.
  • Gardegard, N. (2004). Workplaces against drugs. The Sundsvall experience. Tackling alcohol and other drugs in the workplace and in the local community. Harnosand, Sweden: Norra Forlaget.
  • GlaxoSmithKline. (n.d.). The GlaxoSmithKline IMPACT Awards. Retrieved July 2, 2010, from http://www.gsk.com/community/ impact_awards_uk.htm
  • Graham, A., Pfeifer, J., Trumble, J., & Nelson, E., D. (1999). A pilot project: Continuing education for pharmacists on substance abuse prevention. Substance Abuse, 20(1), 33–43.
  • Haig, M., & Jones, M. T. (2006). The drivers of corporate social responsibility: A critical review. The Business Review, Cambridge 5(2), 45–52.
  • HBO. (n.d.). Addiction. Retrieved June 30, 2010, from http:// www.hbo.com/addiction/
  • Heirich, M., & Sieck, C. J. (2000). Worksite cardiovascular wellness programs as a route to substance abuse prevention. Journal of Occupational and Environmental Medicine, 42, 47–56.
  • Henderson, M., Hutcheson, G., & Davies, J. (1996). Alcohol and the workplace. Copenhagen: WHO Regional Publications, European Series, 67.
  • Hungarian Ministry of Social Affairs and Labour. (n d.). Nemzeti strategia a kabitoszer-problema kezelesere 2010–2018 [National strategy to combat the drug problem 2010–2018]. Retrieved June 18, 2010, from http://www.szmm.gov.hu/ main.php?folderID=900
  • Hungarian Ministry of Youth and Sport. (1999). National strategy to combat the drug problem: Conceptual framework of the Hungarian Government's anti-drug strategy. Budapest, Hungary: Hungarian Ministry of Youth and Sport.
  • International Labour Organization. (n.d.). Model workplace substance abuse prevention programmes in Slovenia. Retrieved February 4, 2011. from http://ilo-mirror.library.cornell.edu/ public/english/protection/safework/drug/modslv.htm
  • Jalbert, J. J., Quilliam, B. J., & Lapane, K., L. (2008). A profile of concurrent alcohol and alcohol-interactive prescription drug use in the US population. Journal of General Internal Medicine, 23(9), 1318–1323.
  • Kaucsek, G., & Simon, P. (2009, September). Beszamolo a munkahelyi megelozesi programok aktualis helyzeterol [Report on the current state of workplace prevention programs]. Report presented at the session of the Inter-ministerial Drug Committee of the Hungarian Parliament, Budapest, Hungary.
  • Kek Pont. (n.d.). EgeszsegIskola [Health School]. Retrieved January 14, 2011, from http://www.kekpont.hu/egeszsegiskola.htm
  • Knowles, E. A., & Riccucci, N. M. (2001). Drug testing in the public sector: An interpretation grounded in Rosenbloom's Competing-perspectives model. Public Administration Review, 61(4), 424–431.
  • Larson, S. L., Eyerman, J., Foster, M. S., & Gfroerer, J.C. (2007). Worker substance use and workplace policies and programs (DHHS Publication No. SMA 07–4273, Analytic Series A-29). Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
  • Magyar Telekom. (n.d.). Telefonos lelkisegely-szolgalatok tamogatasa [Donation for mental health helpline services]. Retrieved July 7, 2008, from http://www.magyartelekom.hu/docs/ telefonos_lelkisegely_kedvezmenyezettek.pdf
  • Magyar Telekom. (2010). Virtual cannabis outpatient consulting to be launched with Magyar Telekom's support. Retrieved January 14, 2011, from http://www.telekom.hu/press_room/ press_releases/2010/may_31_2
  • McBarnet, D., Voiculescu, A., & Campbell, T. (2007). The New Corporate Accountability: Corporate Social Responsibility and the Law. Cambridge, Cambridge University Press.
  • Miniska, I., & Incze, A. (2008). Beyond what is required. MOL Scientific Magazine, SD & HSE Special Issue, 101–113. Retrieved June 22, 2010, from http://www.mol.hu/en/about_mol/ news_media_centre/our_publications/mol_scientific_magazine/ sd_hse_special_issue/beyond_what_is_required/
  • Mitchell, R. K., Agle, B. R., & Wood, D. J. (1997). Toward a theory of stakeholder identification and salience. Academy of Management Review, 22(4), 853–886.
  • Moon, J., Slager, R., Brunn, C., Hardi, P., & Knudsen, J.S. (2012). Analysis of the national and EU policies supporting corporate social responsibilities and impacts. IMPACT Working Paper Series (2). Retrieved February 11, 2013 from
  • Moore, J. (1989). Drug testing and corporate responsibility: The “ought implies can” argument. Journal of Business Ethics, 8, 279–287.
  • National Employment Service. (n.d.). Retrieved January 5, 2011, from http://internet.afsz.hu/engine.aspx?page=mhelyi_ alk_es_drogm
  • National Institute on Drug Abuse. (n.d.). Prescription Medications. Retrieved February 23, 2010, from http://www.drugabuse. gov/DrugPages/prescription.html
  • National Institute on Drug Abuse. (2010). Prescription Drug Abuse: A research update from the National Institute on Drug Abuse. Retrieved January 7, 2011, from http://www.drugabuse. gov/tib/prescription.html
  • Office of National Drug Control Policy. (2011). Epidemic: Responding to America's Prescription Drug Abuse Crisis. Retrieved February 04, 2013, from http://www.whitehouse.gov/ sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf
  • Paik, L. (2006). Organizational interpretations of drug test results. Law & Society Review, 40(4), 931–962.
  • Porter, M. E., & Kramer, M. R. (2006). Strategy and society: The link between competitive advantage and corporate social responsibility. Harvard Business Review, December, 2006, 1–14.
  • Purdue. (n.d.). Prescription drug safety: Providing relief, preventing abuse. Retrieved February 05, 2013, from http://www.purduepharma.com/programs-resources/prescription-drug-safety/
  • Radacsi, G. (2010). Substance abuse prevention and corporate social responsibility: Attitudes, obstacles and possibilities in the Hungarian context. Saarbruecken, Germany: LAP Lambert Academic Publishing.
  • Rayp, G., & Van De Sijpe, N. (2007). Measuring and explaining government efficiency in developing countries. The Journal of Development Studies 43(2). 360–381
  • Reitox National Focal Point, 2009. Hungary. New developments, trends, and in-depth information on selected issues: 2009 National report to the EMCDDA by the Reitox National Focal Point. Retrieved January 7, 2011, from http://drogfokuszpont. hu/?lang=2
  • Reitox National Focal Point, 2010. Hungary. New developments, trends, and in-depth information on selected issues: 2010 National report to the EMCDDA by the Reitox National Focal Point. Retrieved January 7, 2011, from
  • Robert Wood Johnson Foundation. (2007). Fighting Back (R). Retrieved January 6, 2011, from http://www.rwjf.org/ reports/npreports/fightingback.htm
  • Roman, P. M., & Blum, T. C. (2002). The workplace and alcohol problem prevention. National Institute on Alcohol Abuse and Alcoholism (NIAAA) Publications. Retrieved June 1, 2010, from http://pubs.niaaa.nih.gov/publications/arh26–1/49–57.htm
  • Rothstein, B., & Teorell, J. J. (2012). Defining and measuring quality of government. In S. Holmberg, & B. Rothstein (Eds.), Good government: The relevance of political science (pp. 6–12). Cheltenham: Edward Elgar.
  • SABMiller plc. (n.d.). Alcohol framework. Retrieved January 6, 2011, from http://www.sabmiller.com/index.asp?pageid=335
  • Saxe, L., & Winick, C. (2001). Drug abuse. Encyclopedia of Sociology (2nd ed., Vol. 1. 710–719). New York: Macmillan Reference.
  • Schulden, J. D., Yonette, T. F., & Compton, W. M. (2009). Substance abuse in the United States: Findings from recent epidemiologic studies. Current Psychiatry Reports, 11, 353–359.
  • Steele, P. (1998). Employee assistance programs: Then, now, and in the future. Presented at the Center for Substance Abuse Prevention's Knowledge Exchange Workshop, Tacoma, WA.
  • Talisman Energy Inc. (2007). Corporate responsibility report 2007. Retrieved June 23, 2010, from http://www.talisman-energy.com/upload/report_link/16/02/2007crreport-final.pdf
  • Tar, Zs. (2002). Hatekony a vandor-drogkiallitas [Effective drug-exhibition road show]. Magyar Nemzet Online. Retrieved January 14, 2011, from http://www.mno.hu/portal/116775
  • United Nations. (1998). Declaration on the guiding principles of drug demand reduction. General Assembly. 9th plenary meeting, 1998, June 10.
  • United Nations. (2009a). Draft political declaration and plan of action on international cooperation towards an integrated and balanced strategy to counter the World drug problem. Economic and Social Council, Commission on Narcotic Drugs. 52nd session. 2009, March 11–20, Vienna.
  • United Nations. (2009b). Draft political declaration and plan of action on international cooperation towards an integrated and balanced strategy to counter the World drug problem. Addendum: Plan of action. Economic and Social Council, Commission on Narcotic Drugs. 52nd session. 2009, March 11–20, Vienna.
  • United Nations Office on Drugs and Crime. (2012). World Drug Report 2012. United Nations publication, Sales No. E.12. XI.1.
  • Wood, D. J. (1991). Corporate social performance revisited. Academy of Management Review, 16, 691–718.
  • World Health Organization. (2001). Declaration on young people and alcohol. WHO European Ministerial Conference on Young People and Alcohol. 2001, February 21, Stockholm.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.